Table 2. Association between corticosteroids and mortality.

Group	# ofdeaths	Subjects receiving ≥2vasoactive medications # (%)	OR	95% C.I.	P value
All subjects (n = 496)	64	242 (49)	2.304	1.312–4.046	0.004
Low risk subjects (n = 323)	7	132 (41)	6.898	0.821–57.595	0.075
Intermediate risk subjects (n = 117)	27	66 (56)	1.371	0.563–3.343	0.487
High risk subjects (n = 56)	30	44 (79)	2.333	0.780–6.980	0.130